MEDIGEN BIOTECHNOLOGY CORPORATION financial statements, including revenue, expenses, profit, and loss

The total revenue of 3176 for the last quarter is 436.64 M TWD, and it's 23.31% higher compared to the previous quarter. The net income of Q3 24 is -13.42 M TWD.